-
1
-
-
0036533777
-
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer
-
Borner MM, Dietrich D, Stupp R et al (2002) Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. J Clin Oncol 20:1759-1766
-
(2002)
J Clin Oncol
, vol.20
, pp. 1759-1766
-
-
Borner, M.M.1
Dietrich, D.2
Stupp, R.3
-
2
-
-
2942638081
-
XELOX (capecitabine plus oxaliplatin): Active first-line therapy for patients with metastatic colorectal cancer
-
Cassidy J, Tabernero J, Twelves C, et al (2004) XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Onc 22:2084-2091
-
(2004)
J Clin Onc
, vol.22
, pp. 2084-2091
-
-
Cassidy, J.1
Tabernero, J.2
Twelves, C.3
-
3
-
-
27644540140
-
Oxaliplatin (OXA) plus levo-folinic acid (1-FA) and 5-fluorouacil (FU) i.v. bolus (OXAFAFU) is more active than irinotecan (IRI) plus levo-folinic acid (1-FA) and 5-fluorouacil (FU) i.v. bolus (IR-IFAFU) in advanced colorectal carcinoma (ACC): Final results of the Southern Italy Cooperative Oncology Group (SICOG) trial 0103
-
abstract# 271PD
-
Comella P, Massidda B, Filippelli G, et al (2004) Oxaliplatin (OXA) plus levo-folinic acid (1-FA) and 5-fluorouacil (FU) i.v. bolus (OXAFAFU) is more active than irinotecan (IRI) plus levo-folinic acid (1-FA) and 5-fluorouacil (FU) i.v. bolus (IR-IFAFU) in advanced colorectal carcinoma (ACC): Final results of the Southern Italy Cooperative Oncology Group (SICOG) trial 0103. Ann Oncol 15 (Supplement 3): iii72, abstract# 271PD
-
(2004)
Ann Oncol
, vol.15
, Issue.3 SUPPL.
-
-
Comella, P.1
Massidda, B.2
Filippelli, G.3
-
5
-
-
9744230871
-
OPTIMOX study: FOLFOX7/LV5FU2 compared to FOLFOX4 in patients with advanced colorectal cancer
-
abstract# 3525
-
De Gramont A, Cervantes A, André T et al (2004) OPTIMOX study: FOLFOX7/LV5FU2 compared to FOLFOX4 in patients with advanced colorectal cancer. Proc Am Soc Clin Oncol 251s, abstract# 3525
-
(2004)
Proc Am Soc Clin Oncol
-
-
De Gramont, A.1
Cervantes, A.2
André, T.3
-
6
-
-
6444230253
-
A phase II study of Gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer
-
abstract# 3514
-
Fisher GA, Kuo T, Cho CD et al (2004) A phase II study of Gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol 248s, abstract# 3514
-
(2004)
Proc Am Soc Clin Oncol
-
-
Fisher, G.A.1
Kuo, T.2
Cho, C.D.3
-
7
-
-
1842569206
-
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
-
Goldberg RM, Sargent DJ, Morton RF et al (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30
-
(2004)
J Clin Oncol
, vol.22
, pp. 23-30
-
-
Goldberg, R.M.1
Sargent, D.J.2
Morton, R.F.3
-
8
-
-
2142730276
-
Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): Updated results of a randomized phase II trial
-
abstract# 295
-
Grothey A, Jordan K, Kellner O et al (2003) Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial. Eur J Cancer S90, abstract# 295
-
(2003)
Eur J Cancer
-
-
Grothey, A.1
Jordan, K.2
Kellner, O.3
-
9
-
-
0035871538
-
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
-
Hoff PM, Ansari R. Batisti G et al (2001) Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19:2282-2292
-
(2001)
J Clin Oncol
, vol.19
, pp. 2282-2292
-
-
Hoff, P.M.1
Ansari, R.2
Batisti, G.3
-
10
-
-
33845382806
-
Non-parametric estimation from incomplete observations
-
Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
11
-
-
0033636033
-
Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer
-
Oncology Multidisciplinary Research Group (GERCOR)
-
Maindrault-Gœbel F, de Gramont A, Louvet C et al (2000) Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR). Ann Oncol 11:1477-1483
-
(2000)
Ann Oncol
, vol.11
, pp. 1477-1483
-
-
Maindrault-Gœbel, F.1
De Gramont, A.2
Louvet, C.3
-
12
-
-
0035032625
-
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)
-
Maindrault-Gœbel F, de Gramont A, Louvet C et al (2001) High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7). Eur J Cancer 37:1000-1005
-
(2001)
Eur J Cancer
, vol.37
, pp. 1000-1005
-
-
Maindrault-Gœbel, F.1
De Gramont, A.2
Louvet, C.3
-
14
-
-
0037837645
-
Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer
-
Scheithauer WS, Kornek GV, Raderer M, et al (2003) Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 21:1307-1312
-
(2003)
J Clin Oncol
, vol.21
, pp. 1307-1312
-
-
Scheithauer, W.S.1
Kornek, G.V.2
Raderer, M.3
-
15
-
-
0024536437
-
Optimal two stage design for phase II clinical trials
-
Simon R (1989) Optimal two stage design for phase II clinical trials. Contr Clin Trial 10:1-10
-
(1989)
Contr Clin Trial
, vol.10
, pp. 1-10
-
-
Simon, R.1
-
16
-
-
6444243519
-
An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLOFOX-4) in the first-line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR): Preliminary results
-
abstract# 3512
-
Tabernero JM, Van Cutsem E, Sastre J et al (2004) An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLOFOX-4) in the first-line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR): Preliminary results. Proc Am Soc Clin Oncol 248s, abstract# 3512
-
(2004)
Proc Am Soc Clin Oncol
-
-
Tabernero, J.M.1
Van Cutsem, E.2
Sastre, J.3
-
17
-
-
0036176033
-
Capecitabine as first-line treatment in colorectal cancer: Pooled data from two large, phase III trials
-
Twelves C, on behalf of the Xeloda Colorectal Cancer Group (2002) Capecitabine as first-line treatment in colorectal cancer: pooled data from two large, phase III trials. Eur J Cancer 38:S15-S20
-
(2002)
Eur J Cancer
, vol.38
-
-
Twelves, C.1
-
18
-
-
0035503151
-
Oral capecitabine compared with intravenous 5-fluorouracil plus leucovorin (Mayo Clinic regimen) in patients with metastatic colorectal cancer: Results of a large phase III study
-
Van Cutsem E, Twelves C, Cassidy J et al (2001) Oral capecitabine compared with intravenous 5-fluorouracil plus leucovorin (Mayo Clinic regimen) in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19:4097-4106
-
(2001)
J Clin Oncol
, vol.19
, pp. 4097-4106
-
-
Van Cutsem, E.1
Twelves, C.2
Cassidy, J.3
-
19
-
-
0141725528
-
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer
-
Zeuli M, Nardoni C, Pino MS et al (2003) Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. Ann Oncol 14:1378-1382
-
(2003)
Ann Oncol
, vol.14
, pp. 1378-1382
-
-
Zeuli, M.1
Nardoni, C.2
Pino, M.S.3
|